Literature DB >> 17205534

Aggressive T-cell large granular lymphocyte leukemia: a case report and review of the literature.

Todd J Alekshun1, Jianguo Tao, Lubomir Sokol.   

Abstract

The majority of patients with T-cell large granular lymphocyte (LGL) leukemia will have an indolent clinical course. Herein, we report a case of an aggressive T-cell LGL leukemia in a previously healthy 42-year-old Caucasian male who presented with acute onset of B-symptoms, hepatosplenomegaly, lymphocytosis, moderate anemia, and thrombocytopenia. Immunophenotypically, the malignant cells co-expressed CD3(+)CD8(+)CD56(+) markers and the T-cell receptor beta (TCR beta) gene demonstrated clonal rearrangement. The patient was treated with an intensive chemotherapeutic regimen (hyper-CVAD) and he achieved a complete remission. A systematic review of all available English literature revealed 12 well-described cases of aggressive T-cell LGL leukemia suggesting that this variant is a new and distinct entity in the spectrum of LGL disorders. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 17205534     DOI: 10.1002/ajh.20853

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  14 in total

1.  Hematopoietic stem cell transplantation for T-cell large granular lymphocyte leukemia: a retrospective study of the European Society for Blood and Marrow Transplantation.

Authors:  T Marchand; T Lamy; H Finel; W Arcese; S Choquet; J Finke; A Huynh; G Irrera; D Karakasis; J Konopacki; J Lambert; M Michieli; H C Schouten; W Schroyens; G Sucak; J Tischer; E Vandenberghe; P Dreger
Journal:  Leukemia       Date:  2015-09-22       Impact factor: 11.528

2.  A novel mouse model for the aggressive variant of NK cell and T cell large granular lymphocyte leukemia.

Authors:  Akihiko Yokohama; Anjali Mishra; Takeki Mitsui; Brian Becknell; Jessica Johns; Douglas Curphey; Bradley W Blaser; Jeffrey B Vandeusen; Hsiaoyin Mao; Jianhua Yu; Michael A Caligiuri
Journal:  Leuk Res       Date:  2009-08-05       Impact factor: 3.156

Review 3.  The legacy of the F344 rat as a cancer bioassay model (a retrospective summary of three common F344 rat neoplasms).

Authors:  Robert R Maronpot; Abraham Nyska; Jennifer E Foreman; Yuval Ramot
Journal:  Crit Rev Toxicol       Date:  2016-06-09       Impact factor: 5.635

4.  CD56 Negative Aggressive T Cell Large Granular Lymphocytic Leukemia.

Authors:  Mary Theresa Sylvia; Sajini Elizabeth Jacob; Debdatta Basu; Deepak Amalnath; Tarun Kumar Dutta
Journal:  Indian J Hematol Blood Transfus       Date:  2015-01-13       Impact factor: 0.900

Review 5.  The pathogenesis and treatment of large granular lymphocyte leukemia.

Authors:  Steven Nathaniel Steinway; Francis LeBlanc; Thomas P Loughran
Journal:  Blood Rev       Date:  2014-03-07       Impact factor: 8.250

6.  Complete remission of aggressive T-cell LGL leukemia with pentostatin therapy: first case report.

Authors:  Margaret Li Krackeler; Catherine Broome; Catherine Lai
Journal:  Stem Cell Investig       Date:  2020-12-29

Review 7.  Large granular lymphocyte leukemia.

Authors:  Lubomir Sokol; Thomas P Loughran
Journal:  Curr Hematol Malig Rep       Date:  2007-10       Impact factor: 3.952

Review 8.  Large granular lymphocytic leukemia: a brief review.

Authors:  Ekta Rahul; Aparna Ningombam; Shreyam Acharya; Pranay Tanwar; Amar Ranjan; Anita Chopra
Journal:  Am J Blood Res       Date:  2022-02-15

9.  Asymptomatic T-cell large granular lymphocyte leukemia with an unusual immunophenotype.

Authors:  Panagiota K Petsa; Achilleas Karamoutsios; Lefkothea Dova; Leonidas Benetatos; Asimina Petsiou; Nikolaos Kolaitis; Antonis Georgopoulos; Georgios Vartholomatos
Journal:  Clin Pract       Date:  2012-06-27

10.  Lack of common TCRA and TCRB clonotypes in CD8(+)/TCRαβ(+) T-cell large granular lymphocyte leukemia: a review on the role of antigenic selection in the immunopathogenesis of CD8(+) T-LGL.

Authors:  Y Sandberg; M J Kallemeijn; W A Dik; D Tielemans; I L M Wolvers-Tettero; E J van Gastel-Mol; T Szczepanski; Y Pol; N Darzentas; J J M van Dongen; A W Langerak
Journal:  Blood Cancer J       Date:  2014-01-10       Impact factor: 11.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.